Rudolf A. de Boer - Concepedia

Author

Rudolf A. de Boer

University Medical Center Groningen ORCID

Also Known As

Bakker, Stephan J L, Best, Lyle G., Boer, Rudolf A. De, Brian P. Halliday, Bruce H. R. Wolffenbuttel, C Grande, De Boer, R. A., Dirk Van Veldhuisen, E. Shyong Tai, ESC Scientific Document Group

Publications

81.2K

Citations

129

H-Index

229

Concepts

All Affiliations

University Medical Center Groningen University of Groningen University of Glasgow Erasmus MC Harvard University

About

Rudolf A. de Boer is an author at University Medical Center Groningen specializing in medicine, cardiovascular disease, and heart failure.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	48	111	8.6K
2	Health Sciences	16	16	1.4K
3	Engineering	6	6	263
4	Natural Sciences	2	2	92
5	Nursing	2	2	33

Rudolf A. de Boer

400

Publications

48K

Citations

H-Index

Page 1

	Year	Citations
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction John J.V. McMurray, Scott D. Solomon, Silvio E. Inzucchi, New England Journal of Medicine	2019	6.4K
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) Alexander R. Lyon, Teresa López‐Fernández, Liam S. Couch, European Heart Journal	2022	2.4K
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction Scott D. Solomon, John J.V. McMurray, Brian Claggett, New England Journal of Medicine	2022	2.4K
2023 ESC Guidelines for the management of cardiomyopathies Elena Arbelo, Alexandros Protonotarios, Juan R. Gimeno, European Heart Journal	2023	2K
How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) Burkert Pieske, Carsten Tschöpe, Rudolf A. de Boer, European Heart Journal	2019	1.7K
Identification of seven loci affecting mean telomere length and their association with disease Veryan Codd, Christopher P. Nelson, Eva Albrecht, Nature Genetics Genetic DisorderGeneticsMean Telomere LengthPathologyMolecular Genetics	2013	949
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society Alexander R. Lyon, Susan Dent, Susannah Stanway, European Journal of Heart Failure	2020	717
Clinical Practice Update on Heart Failure 2019: Pharmacotherapy, Procedures, Devices and Patient Management. An Expert Consensus Meeting Report of the Heart Failure Association of the European Society of Cardiology Petar Seferović, Piotr Ponikowski, Stefan D. Anker, European Journal of Heart Failure	2019	600
Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND Frank P. Brouwers, Rudolf A. de Boer, Pim van der Harst, European Heart Journal	2013	593
Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction Rudolf A. de Boer, Dirk J. Lok, Tiny Jaarsma, Annals of Medicine	2010	582

Page 1